Both in Pharmaceuticals
Matinas BioPharma Holdings vs Artelo Biosciences
Over the past year MTNB returned −93.8% and ARTL returned −95.5%; their daily moves had a correlation of -0.01.
MTNB −93.8% ARTL −95.5%Growth of $1, one year, split-adjusted
| Metric | MTNB | ARTL |
|---|---|---|
| Price | $1.19 | $2.27 |
| Market cap | $1.2M | $1.2M |
| Today | +4.39% | −5.42% |
| 1 month | −60.5% | −34.4% |
| 6 months | −88.3% | −90.9% |
| Year to date | −86.5% | −93.1% |
| 1 year | −94.1% | −97.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $755.0K | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 775.7% | 650.5% |
| Short % of float | 0.5% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).